CoEHAR researchers opposes study findings on pulmonary inflammation caused by vaping

According to Prof. Polosa: “The study does not present any causality between data and the hypothesis according to which there would be health complications for vapers”, In fact, as the scientist explains: “The very small sample size and low reproducibility of the tests does not allow us to give a precise and scientific answer on pulmonary inflammation caused by vaping because it does not take into consideration fundamental factors, such as the prior exposure to tobacco smoking”.

Continue ReadingCoEHAR researchers opposes study findings on pulmonary inflammation caused by vaping

EU: public consultation on the “Evaluation of the legislative framework for tobacco control”

The European Commission has launched a public consultation on the "Evaluation of the legislative framework for tobacco control" which allows citizens, experts, industries and all stakeholders to express their opinion on the revision of the Tobacco Directive (TPD) through filling in a multiple-choice questionnaire, and sharing a final opinion of up to 500 characters.

Continue ReadingEU: public consultation on the “Evaluation of the legislative framework for tobacco control”

IOF-ESCEO 2023: CoEHAR at the World Congress on osteoporosis

To present the latest news regarding harm reduction strategies in the prevention of bone diseases, prof. Riccardo Polosa, Founder of the CoEHAR, and prof. Giovanni Li Volti, Director of the center, will attend the 2023 edition of the IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases from May 4 to May 7 in Barcelona

Continue ReadingIOF-ESCEO 2023: CoEHAR at the World Congress on osteoporosis

CoEHAR researchers’ “guidebook”: how to identify data misinterpretations in ecig studies

Researchers from CoEHAR's In Silico Science project have developed a two-step technique to identify spin bias, research reporting that results in an intentional or unintentional misinterpretation of research results.

Continue ReadingCoEHAR researchers’ “guidebook”: how to identify data misinterpretations in ecig studies

Rome – Health, focus on “Global clinical risk: causes and intervention strategies”

One of the speakers of the event, moderated by Prof. Carla Bruschelli, was Prof. Riccardo Polosa, founder of CoEHAR, Center of Excellence for the acceleration of Harm Reduction, and professor of Internal Medicine at the University of Catania. The subject of his speech was the patient with COPD (Chronic Obstructive Pulmonary Disease) with addiction to smoking, which he defined as "a difficult patient, because he has a long history that has created a strong alliance with cigarettes. Therefore, giving up smoking leads him to a great form of distress, because it represents a loss”.

Continue ReadingRome – Health, focus on “Global clinical risk: causes and intervention strategies”

CEASEFIRE: first study in the world to assess the efficacy and safety of heated tobacco products and e-cig as a valid smoking cessation tool

“We observed an improvement in exercise tolerance in participants compared to the initial levels: many patients from the first month declared that they have more breath and to feel less fatigue in small but important daily activities such as climbing stairs or doing household” - added prof. Pasquale Caponnetto, professor of clinical psychology at DISFOR of the University of Catania and CoEHAR member.

Continue ReadingCEASEFIRE: first study in the world to assess the efficacy and safety of heated tobacco products and e-cig as a valid smoking cessation tool